Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Smith & Nephew SNATS Inc (SNN)

  • Business News
  • Jan. 02, 2026, 10:11 UTC
  • 10
  • 1 comments

Smith+Nephew PLC Notification

Market reaction Comment Full text

BridgeBio Pharma (BBIO)

  • Business News
  • Jan. 02, 2026, 06:34 UTC
  • 11
  • 1 comments

BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 02, 2026, 06:30 UTC
  • 9
  • 1 comments

How to Turn Off Sticky Keys in Windows 11 (Step‑by‑Step)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 02, 2026, 06:27 UTC
  • 11
  • 1 comments

WASD Keys Acting Like Arrow Keys (or Vice Versa)

Market reaction Comment Full text

Ecovyst Inc. (ECVT)

  • Business News
  • Jan. 02, 2026, 06:00 UTC
  • 12
  • 1 comments

Ecovyst Completes Sale of Advanced Materials & Catalysts Segment to Technip Energies

Market reaction Comment Full text

Hyphens Pharma International Limited (1J5)

  • Business News
  • Jan. 02, 2026, 03:05 UTC
  • 12
  • 1 comments

Hyphens Notification - Appointment of Chief Commercial Officer

Market reaction Comment Full text

Clinuvel Pharmaceuticals Ltd. (CLVLF)

  • Business News
  • Jan. 02, 2026, 02:06 UTC
  • 8
  • 1 comments

Notification of cessation of securities

Market reaction Comment Full text

Hyphens Pharma International Limited (1J5)

  • Business News
  • Jan. 01, 2026, 22:57 UTC
  • 9
  • 1 comments

Appointment of Chief Commercial Officer

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Jan. 01, 2026, 22:38 UTC
  • 15
  • 1 comments

Mesoblast Announces Changes to Board of Director Roles

Market reaction Comment Full text

XOMA Corporation (XOMA)

  • Business News
  • Jan. 01, 2026, 15:00 UTC
  • 14
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

Market reaction Comment Full text
  • Previous
  • 194
  • 195
  • 196
  • 197
  • 198
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2261)
  • SEC News(189437)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124580)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin